The Superbugs and Superdrugs conference addressed the core challenges in the industry from: Investment, R&D to hospital hygiene, consumer engagement and reviewed current strategies.
Jean-Pierre Paccaud, Business Development Director from DNDi, discussed global product development partnerships as a means of fostering new antibiotic treatments and their responsible use.
Session
Date: Wednesday, March 16, 2016
| A Global Health R&D Approach to Innovation, Conservation, and Access to New Antibiotic Treatments Jean-Pierre Paccaud, Business Development Director, DNDi |
More information: SMI Events website
